Skip to main content
Premium Trial:

Request an Annual Quote

Caliper Said Q1 Receipts Climb 9 Percent as Net Losses Fall by Half

NEW YORK, May 5 (GenomeWeb News) - Caliper today said that total first-quarter revenues increased 9 percent as net loss declined 51 percent.


Total receipts for the three months ended March 31 increased to $18.4 million from $16.9 million in the similar period of 2004.


Spending on R&D fell to $3.9 million in the quarter from $6.2 million year over year.


Caliper said net loss for the quarter narrowed to $4.9 million, or $.16 per share, from $10 million, or $.35 per share, in the first quarter of 2004.


The company had around $9.9 million in cash and cash equivalents as of March 31.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.